Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 7Lymphoma, Large B-Cell, Diffuse 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Leukemia 3Lymphoma, Large-Cell, Anaplastic 2Sezary Syndrome 1Respiratory Tract Diseases 1Rare Diseases 1Prostatic Neoplasms 1Nausea 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Biphenotypic, Acute 1Immunoblastic Lymphadenopathy 1Hormone Refractory Prostate Cancer 1Hemangioma 1Esophageal Stenosis Acquired 1Dendritic Cell Sarcoma, Interdigitating 1COVID-19 1Ataxia Telangiectasia 1Ataxia 1

Interventions

Aprepitant 8Dexamethasone 7Calcium Dobesilate 7Ondansetron 6dexamethasone acetate 5Therapeutics 5Doxorubicin 5Vincristine 4Palonosetron 4Cyclophosphamide 4dexamethasone 21-phosphate 3Psychiatric Rehabilitation 3Granisetron 3peppermint oil 2auricularum 2Yoga 2Rituximab 2Music Therapy 2Mesna 2Lorazepam 2Ifosfamide 2Control Groups 2Aromatherapy 2Acupressure 2stinging nettle lectin 1salicylhydroxamic acid 1fosaprepitant 1dolasetron 1almond oil 1Whole Body Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Nausea × Prednisone × Clear all
NCT00651755 2013-07-02

Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients

M.D. Anderson Cancer Center

Phase NA Completed
23 enrolled 14 charts
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea

Data powered by HemOnc (CC BY 4.0) Colophon âš¡